|
Symbol Name ID |
Sesn2
sestrin 2 MGI:2651874 |
Excel File
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| Lepob/Lepob Sesn2Gt(RRJ141)Byg/Sesn2Gt(RRJ141)Byg involves: 129P2/OlaHsd * C57BL/6 |
decreased fatty acid beta-oxidation | J:189021 |
| hepatic steatosis | J:189021 | |
| impaired glucose tolerance | J:189021 | |
| increased circulating glucose level | J:189021 | |
| increased liver triglyceride level | J:189021 | |
| increased urine glucose level | J:189021 | |
| insulin resistance | J:189021 | |
| Ltbp4Gt(U3Cre)1Vmel/Ltbp4Gt(U3Cre)1Vmel Sesn2Gt(W077E06)Wrst/Sesn2Gt(W077E06)Wrst involves: 129S2/SvPas * C57BL/6 |
overexpanded pulmonary alveolus | J:160854 |
| normal respiratory system phenotype | J:160854 | |
| Sesn2Gt(RRJ141)Byg/Sesn2Gt(RRJ141)Byg Sesn3tm1a(EUCOMM)Wtsi/Sesn3tm1a(EUCOMM)Wtsi involves: 129P2/OlaHsd * C57BL/6N |
normal growth/size/body region phenotype | J:189021 |
| impaired glucose tolerance | J:189021 | |
| insulin resistance | J:189021 | |
| normal liver/biliary system phenotype | J:189021 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 09/30/2025 MGI 6.24 |
|
|
|
||
Analysis Tools